Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03322059 · ClinicalTrials.gov registry record · NA
Evaluating Whether Charity Incentives Motive Cancer Survivors to Increase Physical Activity
A NA study, sponsored by California Polytechnic State University-San Luis Obispo.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT03322059 is a NA study that has completed, run by California Polytechnic State University-San Luis Obispo. The registered enrollment target is 51 participants.
The verdict
NCT03322059, a NA study, has completed, sponsored by California Polytechnic State University-San Luis Obispo.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
The investigators propose to examine whether linking daily activity with charity-based incentives motivates cancer survivors to initiate and maintain physical activity. Linking daily physical activity goals with a cancer specific charity incentive may provide a uniquely salient motivator that promotes increased physical activity among cancer survivors. The investigators will examine whether using activity monitors in combination with charitable incentives leads to greater increases in physical activity compared to activity monitors alone. Target participants includes cancer survivors who are not already active. Physical activity (e.g., steps per day, time in moderate-intensity activity) will be examined at baseline and following a 12-week intervention period using an activPAL accelerometer. After the baseline assessment, both groups will receive a fitbit monitor and informational material designed to increase physical activity. Participants in the fitbit+charity group will have donations made in their name to a cancer charity if they meet daily step goals. Physical activity levels will be monitored using the fitbit device for 6-weeks following the formal intervention period.
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Experimental
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2018-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03322059
The ClinicalTrials.gov registry entry for NCT03322059 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is California Polytechnic State University-San Luis Obispo, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT03322059 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03322059 about?
NCT03322059 is a clinical study titled "Evaluating Whether Charity Incentives Motive Cancer Survivors to Increase Physical Activity". The investigators propose to examine whether linking daily activity with charity-based incentives motivates cancer survivors to initiate and maintain physical activity. Linking daily physical activity goals with a cancer specific charity incentive may provide a uniquely salient motivator that promot...
What is the current status of trial NCT03322059?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2017-11-01. Estimated completion is 2018-12-01.
What interventions are being tested in trial NCT03322059?
The interventions under investigation include: Control (BEHAVIORAL), Experimental (BEHAVIORAL).
Who is sponsoring clinical trial NCT03322059?
This trial is sponsored by California Polytechnic State University-San Luis Obispo, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.